Further studies taking into consideration the type of mutation, the familial history of renal cancer, and non-genetic risk factors in addition to CHEK2 genotype could refine the degree of risk for these patients, and thus better define the management of CHEK2 mutations for predisposition to renal cancer. Here, CHEK2 is linked to renal carcinoma.